References
- Vander Heiden MG. Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov 2011; 10:671 - 84; http://dx.doi.org/10.1038/nrd3504; PMID: 21878982
- Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell 2008; 13:472 - 82; http://dx.doi.org/10.1016/j.ccr.2008.05.005; PMID: 18538731
- Geschwind JF, Georgiades CS, Ko YH, Pedersen PL. Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma. Expert Rev Anticancer Ther 2004; 4:449 - 57; http://dx.doi.org/10.1586/14737140.4.3.449; PMID: 15161443
- Ganapathy-Kanniappan S, Vali M, Kunjithapatham R, Buijs M, Syed LH, Rao PP, et al. 3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy. Curr Pharm Biotechnol 2010; 11:510 - 7; http://dx.doi.org/10.2174/138920110791591427; PMID: 20420565
- Glunde K, Bhujwalla ZM, Ronen SM. Choline metabolism in malignant transformation. Nat Rev Cancer 2011; 11:835 - 48; PMID: 22089420
- Osmak M. Statins and cancer: current and future prospects. Cancer Lett 2012; 324:1 - 12; http://dx.doi.org/10.1016/j.canlet.2012.04.011; PMID: 22542807
- Dang CV. Links between metabolism and cancer. Genes Dev 2012; 26:877 - 90; http://dx.doi.org/10.1101/gad.189365.112; PMID: 22549953
- Malenda A, Skrobanska A, Issat T, Winiarska M, Bil J, Oleszczak B, et al. Statins impair glucose uptake in tumor cells. Neoplasia 2012; 14:311 - 23; PMID: 22577346
- Littman ML, Taguchi T, Mosbach EH. Effect of cholesterol-free, fat-free diet and hypocholesteremic agents on growth of transplantable animal tumors. Cancer Chemother Rep 1966; 50:25 - 45; PMID: 5908736
- Dimitroulakos J, Nohynek D, Backway KL, Hedley DW, Yeger H, Freedman MH, et al. Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach. Blood 1999; 93:1308 - 18; PMID: 9949174
- Weber G, Convery HJ, Lea MA, Stamm NB. Feedback inhibition of key glycolytic enzymes in liver: action of free fatty acids. Science 1966; 154:1357 - 60; http://dx.doi.org/10.1126/science.154.3754.1357; PMID: 4288679
- Jenkins CM, Yang J, Sims HF, Gross RW. Reversible high affinity inhibition of phosphofructokinase-1 by acyl-CoA: a mechanism integrating glycolytic flux with lipid metabolism. J Biol Chem 2011; 286:11937 - 50; http://dx.doi.org/10.1074/jbc.M110.203661; PMID: 21258134
- Clendening JW, Penn LZ. Targeting tumor cell metabolism with statins. Oncogene 2012; 31:4967 - 78; http://dx.doi.org/10.1038/onc.2012.6; PMID: 22310279